KIT and gastrointestinal stromal tumor: Oncogenic c-Kit mutations (~85%) in GIST result in constitutive RTK activation: the most common exon 11 juxtamembrane domain mutations (~70%) (proximal and distal) [8] are IM sensitive [3].